Getinge AB

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 04:15:59 2024-06-27 EDT			5-day change	1st Jan Change
180.8 ^SEK	-0.21%		+0.95%	-19.84%

05-15	Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders	DJ
05-15	Getinge Shares Sink After It Limits Sales of Heart Devices	DJ

Getinge AB Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

September 19, 2023 at 08:00 am

Getinge announced that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately. Jeanette Hedén Carlsson will continue in her current role until December 31, 2023.

Latest news about Getinge AB

Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders	05-15	DJ
Getinge Shares Sink After It Limits Sales of Heart Devices	05-15	DJ
Getinge Seeks Acquisitions	05-15	CI
Transcript : Getinge AB - Analyst/Investor Day	05-15
Getinge limits sale of heart devices in the US after FDA warning	05-15	RE
Getinge to Limit Some U.S. Cardiovascular-Device Sales After FDA Letter	05-14	DJ
Getinge Shares Sink After FDA Warns on Heart Devices	05-10	DJ
Europe's STOXX 600 hits record high on earnings, rate cut optimism	05-10	RE
US FDA advises healthcare facilities to switch from Getinge's heart devices	05-08	RE
US FDA recommends healthcare providers switch from Getinge's heart devices	05-08	RE
Soltech Fires Up New Solar Park in Sweden	05-03	MT
GETINGE : Q1 24: Investors look beyond the top-line miss	04-24
Nordic Stocks Closed Up Monday; Getinge Series B Climbed Highest	04-22	DJ
Getinge AB Declares A Dividend, Payable on 29 April 2024	04-22	CI
Transcript : Getinge AB, Q1 2024 Earnings Call, Apr 22, 2024	04-22
Medical gear maker Getinge's Q1 core profit beats expectations	04-22	RE
Getinge AB Reaffirms Sales Guidance for the Year 2024	04-22	CI
Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Getinge’s Covered Stent System Gets EU Medical Device Regulation Certification	04-11	MT
GETINGE : EPS cut (2023: +3.1%, 2024: -10.5%)	04-04
Getinge AB Announces Barbro Fridén Declines Re-Election from the Board	03-15	CI
Getinge AB Proposes Dividend, Payable on April 29, 2024	03-15	CI
Getinge’s Endoscopic Vessel Harvesting System Gets US FDA 510(k) Clearance	03-08	MT
Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3	03-08	CI
Global markets live: Boeing, Bayer, Super Micro Computer, Macy's...	03-04

Chart Getinge AB

Duration

Period

More charts

Company Profile

Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-18 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

GETINGE : Q1 24: Investors look beyond the top-line miss

April 24, 2024 at 02:06 am

More Strategies

Ratings for Getinge AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

181.2 SEK

Average target price

225.4 SEK

Spread / Average Target

+24.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
GETINGE AB	-19.84%	4.67B
SHOCKWAVE MEDICAL	+75.69%	12.57B
MASIMO CORPORATION	+12.50%	7B
PENUMBRA, INC.	-30.50%	6.78B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+9.11%	5.2B
APT MEDICAL INC.	+19.81%	4.26B
ASAHI INTECC CO., LTD.	-21.04%	3.84B
INARI MEDICAL, INC.	-28.39%	2.7B
SKAN GROUP AG	-2.35%	1.98B
NOVOCURE LIMITED	+21.63%	1.95B

Medical Equipment